Cardinal Health (CAH)
NYSEHealth CareMedical - DistributionSnapshot 2026-11-04
$261.93+3.55%
Close 2026-11-04 · 1-day change
NYSEHealth CareMedical - DistributionSnapshot 2026-11-04
QuarterlyIQ Insights · CAH
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -41.5% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 7.3% |
Growth built into the price is above our model estimate.
The price assumes 48.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 1 industry peers
CAH — credit agreement
Dated 2026-08-11
Entry into a Material Definitive Agreement On August 7, 2026, Cardinal Health, Inc., (the “Company”), Wells Fargo Bank, National Association (“WF”), as Administrative Agent, Wells Fargo Securities, LLC, BofA Securities, Inc., Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Goldman Sachs Bank USA and JPMorgan Chase Bank, N.A., Barclays Bank plc, Deutsche Bank AG New York Branch, HSBC Bank USA, National Association, PNC Bank, National Associ…
Why it matters: Other brings together three growth businesses. Faster profit growth there can help offset slower growth in the main drug segment.
Watch forOther segment profit growth reaches at least 15% in FY27, within the company's 15%–18% outlook.
Also watch forOther segment profit growth falls below 15% or the company lowers its FY27 outlook.
Why it matters: The company repurchased $1.4 billion of shares in FY26 and set a lower FY27 plan. Actual repurchases will show how it uses cash.
Watch forFY27 filings show share repurchases near $1 billion for the year.
Also watch forFY27 share repurchases fall well below $1 billion, or the company pauses the plan.
Why it matters: The Nov. 5 report is the first test of the new fiscal-year outlook. EPS below the range would weaken the growth case.
Watch forQ1 FY27 non-GAAP EPS results keep the company on pace for its $12.40–$12.60 FY27 outlook, with no cut to that range.
Also watch forThe company cuts its FY27 non-GAAP EPS outlook below $12.40 or reports results that put the range at risk.
Why it matters: This segment drove much of the recent profit growth. Its FY27 outlook calls for slower growth than the 23% reported in FY26.
Watch forFY27 segment profit growth stays within the guided 8%–11% range. Brand, specialty, or generics gains support results.
Also watch forSegment profit growth falls below 8% year over year or the company cuts its 8%–11% outlook.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$90 on $10,000 · ±0.9% | How much price usually moves either way. |
| Bad day | $252 loss on $10,000 · 2.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,042 loss on $10,000 · 20.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The company raised its cash outlook for FY27. A result below the range would test its cash generation plans.
Watch forFY27 adjusted free cash flow reaches $3.5 billion or more, within the $3.5–$4.0 billion outlook.
Also watch forThe company cuts its adjusted free cash flow outlook below $3.5 billion or reports FY27 cash flow below that level.